Traws Pharma (TRAW) Assets Average (2016 - 2025)
Historic Assets Average for Traws Pharma (TRAW) over the last 13 years, with Q3 2025 value amounting to $14.0 million.
- Traws Pharma's Assets Average rose 160.38% to $14.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.0 million, marking a year-over-year increase of 160.38%. This contributed to the annual value of $23.8 million for FY2024, which is 2322.13% down from last year.
- Traws Pharma's Assets Average amounted to $14.0 million in Q3 2025, which was up 160.38% from $17.3 million recorded in Q2 2025.
- Over the past 5 years, Traws Pharma's Assets Average peaked at $57.7 million during Q4 2021, and registered a low of $13.8 million during Q3 2024.
- For the 5-year period, Traws Pharma's Assets Average averaged around $33.1 million, with its median value being $32.8 million (2023).
- Per our database at Business Quant, Traws Pharma's Assets Average skyrocketed by 15549.97% in 2021 and then crashed by 5196.68% in 2024.
- Over the past 5 years, Traws Pharma's Assets Average (Quarter) stood at $57.7 million in 2021, then dropped by 27.99% to $41.6 million in 2022, then crashed by 40.2% to $24.9 million in 2023, then tumbled by 31.82% to $16.9 million in 2024, then decreased by 17.21% to $14.0 million in 2025.
- Its Assets Average was $14.0 million in Q3 2025, compared to $17.3 million in Q2 2025 and $22.0 million in Q1 2025.